Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD.
Cellini A, Cavarretta CA, Angotzi F, Ruocco V, Serafin A, Danesin N, Pizzi M, Gregianin M, Vio S, Crimì F, Vianello F, Piazza F, Trentin L, Visentin A. Cellini A, et al. Among authors: serafin a. Front Oncol. 2024 Sep 5;14:1419118. doi: 10.3389/fonc.2024.1419118. eCollection 2024. Front Oncol. 2024. PMID: 39301543 Free PMC article.
Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
Hofmann C, Serafin A, Schwerdt OM, Fischer J, Sicklinger F, Younesi FS, Byrne NJ, Meyer IS, Malovrh E, Sandmann C, Jürgensen L, Kamuf-Schenk V, Stroh C, Löwenthal Z, Finke D, Boileau E, Beisaw A, Bugger H, Rettel M, Stein F, Katus HA, Jakobi T, Frey N, Leuschner F, Völkers M. Hofmann C, et al. Among authors: serafin a. Circulation. 2024 Oct 15;150(16):1248-1267. doi: 10.1161/CIRCULATIONAHA.123.067479. Epub 2024 Aug 29. Circulation. 2024. PMID: 39206545 Free PMC article.
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Ruggeri E, Frezzato F, Mouawad N, Pizzi M, Scarmozzino F, Capasso G, Trimarco V, Quotti Tubi L, Cellini A, Cavarretta CA, Ruocco V, Serafin A, Angotzi F, Danesin N, Manni S, Facco M, Piazza F, Trentin L, Visentin A. Ruggeri E, et al. Among authors: serafin a. Front Immunol. 2024 May 14;15:1393485. doi: 10.3389/fimmu.2024.1393485. eCollection 2024. Front Immunol. 2024. PMID: 38807597 Free PMC article.
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Angotzi F, Cellini A, Ruocco V, Cavarretta CA, Zatta I, Serafin A, Pravato S, Pagnin E, Bonaldi L, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A. Angotzi F, et al. Among authors: serafin a. Cancers (Basel). 2024 Mar 8;16(6):1095. doi: 10.3390/cancers16061095. Cancers (Basel). 2024. PMID: 38539430 Free PMC article.
128 results